iSTAR Medical and AbbVie enter strategic alliance for MINIject device

EQT Life Sciences announced that AbbVie and iSTAR Medical entered a strategic transaction to further develop and commercialize iSTAR Medical's MINIject device, a minimally invasive glaucoma surgical device. Deal terms include a $60 million upfront payment to iSTAR Medical.

“Deal terms include a $60M upfront payment to iSTAR Medical.”private-equitynews.com

• 1 source
• private-equitynews.comEQT Life Sciences announces strategic alliance of its portfolio company iSTAR Medical with AbbVie - private-equitynews.comAbout the AuthorSep 20, 2022

Summarized from public sources; check the original articles before acting on it.